Detalhe da pesquisa
1.
A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector.
J Allergy Clin Immunol Glob;
3(2): 100200, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38328805